coronavirus drugs

Biocon Limited, has received the Drug Controller General of India’s (DCGI) approval to market ‘Itolizumab,’ a drug previously used to treat chronic plaque psoriasis, for restricted emergency use on COVID-19 patients.

The government has approved two anti-viral drugs. While Favipiravir is for those with mild to moderate symptoms of coronavirus, Remdesivir is for patients on oxygen support.